πŸ‡ΊπŸ‡Έ FDA
Patent

US 8507433

Cardioprotective effects of GHRH agonists

granted A61KA61K38/25A61P

Quick answer

US patent 8507433 (Cardioprotective effects of GHRH agonists) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/25, A61P, A61P9/10